Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (131-140 of 778) with videos related to

Pageof 78
Sort By:
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy]Antonio Gabriele Franchina, Davide Capodanno
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
The American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21<sup>st</sup> Century: A Review of the EvidenceDominick J Angiolillo, Davide Capodanno
JACC. Cardiovascular Interventions|May 22, 2017
Triple Antithrombotic Therapy at the Intercept Between Threats and Opportunities: Don't Throw Out the Baby With the Bath WaterDavide Capodanno, Dominick J Angiolillo
Circulation|October 13, 2016
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|February 27, 2015
Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelinesDavide Capodanno, Dominick J Angiolillo
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 27, 2024
Editorial: C-reactive protein and TAVR: Impact of inflammation on patient outcomesPlacido Maria Mazzone, Davide Capodanno
Journal of Thrombosis and Thrombolysis|May 6, 2023
Low dose rivaroxaban for the management of atherosclerotic cardiovascular diseasePlacido Maria Mazzone, Davide Capodanno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 2, 2025
Late-Onset Device Related Thrombosis After Left Atrial Appendage Occlusion and Spleen Systemic Embolism: A Case ReportCostanza Agata Bordonaro, Davide Capodanno
Thrombosis and Haemostasis|July 29, 2010
Impact of race and gender on antithrombotic therapyDavide Capodanno, Dominick J Angiolillo
Pageof 78

Showing results (131-140 of 778) with videos related to

Sort By:
Pageof 78
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy]Antonio Gabriele Franchina, Davide Capodanno
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
The American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21<sup>st</sup> Century: A Review of the EvidenceDominick J Angiolillo, Davide Capodanno
JACC. Cardiovascular Interventions|May 22, 2017
Triple Antithrombotic Therapy at the Intercept Between Threats and Opportunities: Don't Throw Out the Baby With the Bath WaterDavide Capodanno, Dominick J Angiolillo
Circulation|October 13, 2016
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|February 27, 2015
Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelinesDavide Capodanno, Dominick J Angiolillo
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 27, 2024
Editorial: C-reactive protein and TAVR: Impact of inflammation on patient outcomesPlacido Maria Mazzone, Davide Capodanno
Journal of Thrombosis and Thrombolysis|May 6, 2023
Low dose rivaroxaban for the management of atherosclerotic cardiovascular diseasePlacido Maria Mazzone, Davide Capodanno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 2, 2025
Late-Onset Device Related Thrombosis After Left Atrial Appendage Occlusion and Spleen Systemic Embolism: A Case ReportCostanza Agata Bordonaro, Davide Capodanno
Thrombosis and Haemostasis|July 29, 2010
Impact of race and gender on antithrombotic therapyDavide Capodanno, Dominick J Angiolillo
Pageof 78